Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.
about
Antiobesity pharmacotherapy: new drugs and emerging targetsThe Resin from Protium heptaphyllum Prevents High-Fat Diet-Induced Obesity in Mice: Scientific Evidence and Potential Mechanisms.Pharmacotherapy for obesity: novel agents and paradigms.Anti-adipogenic and antioxidant effects of the traditional Korean herbal formula Samchulgeonbi-tang: an in vitro study.
P2860
Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical utility of phentermin ...... for the treatment of obesity.
@ast
Clinical utility of phentermin ...... for the treatment of obesity.
@en
type
label
Clinical utility of phentermin ...... for the treatment of obesity.
@ast
Clinical utility of phentermin ...... for the treatment of obesity.
@en
prefLabel
Clinical utility of phentermin ...... for the treatment of obesity.
@ast
Clinical utility of phentermin ...... for the treatment of obesity.
@en
P2860
P356
P1476
Clinical utility of phentermin ...... for the treatment of obesity.
@en
P2093
Jin Hee Shin
Kishore M Gadde
P2860
P304
P356
10.2147/DMSO.S43403
P577
2013-04-08T00:00:00Z